TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Cancer Statistics: Colorectal Cancer Incidence Declines, Annual Report Finds May 19, 2000